Unique, practical knowledge for nurses responsible for daily management of patients with cardiovascular disease, diabetes and related conditions.

CPD Modern medicines series SGLT2 Inhibitors: Webinar 2 - SGLT2 inhibitors and the heart

Modern medicines series SGLT2 Inhibitors: Webinar 2 - SGLT2 inhibitors and the heart

Publication date: Wednesday, 24 February 2021
Contributor(s): Cliff Bailey, Martin Hadley-Brown

Professor Cliff Bailey and Dr Martin Hadley-Brown discuss the effects of SGLT2 inhibitors on cardiovascular function and their role in the management of CV disease, specifically: Cardiovascular disease in type 2 diabetes; SGLT2 inhibitors lower blood pressure; SGLT2 inhibitors reduced heart failure risk; Mechanisms of SGLT2 inhibitors on heart and circulation; Improve BP control independently of other antihypertensives; Reduce risk of new onset or worsening heart failure; May benefit atherosclerotic cardiovascular disease; Positioned in algorithms for type 2 diabetes by CV effects.

Download the factsheet to this webinar below or watch the on-demand video here: View the on-demand webinar

 

This webinar is supported by Boehringer Ingelheim through an unrestricted educational grant

Boehringer Logo small 
Sponsorship information:
This webinar is supported by Boehringer Ingelheim through an unrestricted educational grant.
Topics covered:
Category: Webinars
Edition: Volume 1, Number 2, February 2021
Contributor(s): Cliff Bailey, Martin Hadley-Brown

Article search and filter